KLCM Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
+1,987
New +$177K 0.02% 285
2025
Q2
Sell
-3,215
Closed -$218K 178
2025
Q1
$218K Buy
+3,215
New +$192K 0.03% 156
2024
Q4
Sell
-3,215
Closed -$202K 174
2024
Q3
$202K Sell
3,215
-400
-11% -$23.3K 0.02% 157
2024
Q2
$213K Sell
3,615
-1,109
-23% -$69.4K 0.03% 144
2024
Q1
$377K Buy
4,724
+1,652
+54% +$126K 0.05% 113
2023
Q4
$243K Buy
3,072
+2
+0.1% +$142 0.04% 130
2023
Q3
$214K Buy
3,070
+2
+0.1% +$142 0.04% 124
2023
Q2
$212K Buy
+3,068
New +$218K 0.04% 125
2022
Q4
Sell
-3,223
Closed -$307K 129
2022
Q3
$307K Buy
3,223
+962
+43% +$95.2K 0.07% 97
2022
Q2
$210K Buy
+2,261
New +$221K 0.05% 103
2019
Q4
Sell
-4,344
Closed -$274K 109
2019
Q3
$274K Buy
4,344
+116
+3% +$6.87K 0.07% 80
2019
Q2
$230K Sell
4,228
-170
-4% -$9.15K 0.06% 87
2019
Q1
$237K Buy
+4,398
New +$271K 0.06% 84
2015
Q3
Sell
-4,499
Closed -$472K 87
2015
Q2
$472K Buy
+4,499
New +$460K 0.12% 53

Other funds holding CVS

KLCM Advisors's CVS Position: Q2 2026 in Review

KLCM Advisors opened a new position in CVS Health (CVS) in Q2 2026: 1,987 shares worth $206K. The stake represents 0.02% of the portfolio and ranks #285 among its holdings. This is a return to the name: KLCM Advisors previously reported a position in CVS as recently as Q1 2025.

KLCM Advisors first reported a position in CVS in Q2 2015 and has held it in 14 quarters since. The position peaked at $472K in Q2 2015. 2,070 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • KLCM Advisors held 1,987 shares of CVS Health worth $206K as of Q2 2026.
  • CVS Health was a new KLCM Advisors position in Q2 2026.
  • CVS Health made up 0.02% of KLCM Advisors's portfolio in Q2 2026, its #285 holding.
  • KLCM Advisors first reported a position in CVS Health in Q2 2015 and has held it in 14 quarters since.
  • KLCM Advisors's CVS Health position peaked at $472K in Q2 2015.
  • 2,070 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.